NCT06318390Completed
The Impact of KETO5 XOGenius Beverage on Markers of Physiological and Neurocognitive Health
Source: ClinicalTrials.gov · Last updated 26 Sept 2025
Brief summary (registry, in English)
The primary objectives of this application are to 1) investigate the effect of increased daily consumption of the Keto5 XOGenius beverage on outcomes associated with elevated risk for various neurocognitive and pathophysiological conditions/diseases. And 2) to investigate the effect of daily consumption of the Keto5 XOGenius beverage on the following variables: waist circumference, body weight, and body mass index (BMI).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 6 (actual)
- First submitted
- 12 Mar 2024
- Start date
- 1 Aug 2023
- Primary completion date
- 15 May 2025
- Lead sponsor
- The University of Texas at Arlington
- Diseases
- High blood pressure
- NCT number
- NCT06318390
What you commit to
- Study type: Interventional
- Participants enrolled: 6
- From 1 Aug 2023 to the primary completion date, 15 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently taking any medications that are designed to treat a cardiovascular or metabolic condition
Other illness
- Food allergies
- Type I diabetes/Type II diabetes, and/or a history of hypoglycemia.
- History of irritable bowel syndrome or inflammatory bowel disease.
- Allergy to spandex/lycra/latex
Other
- Individuals who have donated more than 550 ml of blood within the past 8 weeks will not have blood drawn from them in this protocol. However, if they remain interested in the study, and otherwise meet the inclusion criteria, then we may still opt to proceed with data collection.
- Pregnant women
- Breast feeding women
- Anemia
- Use of prescription stimulants
Who the study is looking for
- Men and women who are between the ages of 18-50
Age in the registry: 18 years to 50 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UT Arlington - Science and Engineering Innovation and Research Building Coordinator of this site? Confirm its status | Arlington | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.